BNP PARIBAS FINANCIAL MARKETS - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$95,880
-89.0%
28,200
-76.3%
0.00%
-100.0%
Q2 2023$874,503
-49.9%
118,980
-29.3%
0.00%
-50.0%
Q1 2023$1,744,065
+28.6%
168,346
+46.6%
0.00%0.0%
Q4 2022$1,356,556
-99.9%
114,865
+12.8%
0.00%
-33.3%
Q3 2022$2,137,769,000
-4.5%
101,847
+41.2%
0.00%0.0%
Q2 2022$2,238,419,000
-31.8%
72,114
-9.8%
0.00%
-25.0%
Q1 2022$3,282,870,000
-45.8%
79,953
-42.6%
0.00%
-55.6%
Q4 2021$6,055,241,000
+309.0%
139,297
+371.1%
0.01%
+350.0%
Q3 2021$1,480,620,000
-30.1%
29,571
-12.1%
0.00%
-33.3%
Q2 2021$2,118,921,000
+34.9%
33,639
+98.9%
0.00%
+50.0%
Q1 2021$1,571,015,000
-38.1%
16,909
-40.3%
0.00%
-60.0%
Q4 2020$2,538,637,000
+190.1%
28,333
+234.5%
0.01%
+400.0%
Q3 2020$875,102,000
+88.2%
8,469
+44.1%
0.00%0.0%
Q2 2020$464,911,000
-69.1%
5,879
-77.4%
0.00%
-66.7%
Q1 2020$1,506,906,000
+149.3%
26,044
+132.5%
0.00%
+200.0%
Q4 2019$604,456,000
+40.1%
11,204
+35.8%
0.00%0.0%
Q3 2019$431,415,000
+47.1%
8,252
+35.9%
0.00%0.0%
Q2 2019$293,290,000
-59.2%
6,071
-57.3%
0.00%
-50.0%
Q1 2019$718,799,000
+729.9%
14,228
+873.9%
0.00%
Q4 2018$86,608,000
-80.0%
1,461
-77.8%
0.00%
-100.0%
Q3 2018$433,359,000
+82.0%
6,583
+39.6%
0.00%
Q2 2018$238,111,000
-59.3%
4,716
-57.5%
0.00%
-100.0%
Q1 2018$584,415,000
-63.4%
11,100
-67.7%
0.00%
-66.7%
Q4 2017$1,597,824,000
+118.9%
34,384
+90.6%
0.00%
+50.0%
Q3 2017$729,880,000
+102.3%
18,044
+69.6%
0.00%
+100.0%
Q2 2017$360,836,000
+75.3%
10,641
+50.1%
0.00%0.0%
Q1 2017$205,806,000
-2.0%
7,087
+10.9%
0.00%0.0%
Q4 2016$209,946,000
+29.0%
6,393
+23.8%
0.00%0.0%
Q3 2016$162,758,000
-41.0%
5,162
-47.4%
0.00%0.0%
Q2 2016$275,745,000
+66.7%
9,806
+115.5%
0.00%0.0%
Q1 2016$165,429,000
-31.4%
4,551
-24.5%
0.00%0.0%
Q4 2015$241,260,000
+32.4%
6,030
-5.8%
0.00%
Q3 2015$182,279,000
+119.1%
6,398
+153.4%
0.00%
Q2 2015$83,199,000
+313.3%
2,525
+260.7%
0.00%
Q1 2015$20,132,000
-48.0%
700
-61.5%
0.00%
Q3 2014$38,699,000
+14233.0%
1,816
+15033.3%
0.00%
Q2 2014$270,000
-88.0%
12
-85.9%
0.00%
Q1 2014$2,241,000
-75.5%
85
-78.6%
0.00%
Q4 2013$9,150,0003980.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 119,994$12,399,0006.09%
Hillcrest Asset Management LLC 161,826$16,721,0002.96%
SNYDER CAPITAL MANAGEMENT L P 664,662$68,680,0002.94%
Copper Rock Capital Partners, LLC 83,374$8,615,0002.91%
RICE HALL JAMES & ASSOCIATES, LLC 623,132$64,388,0002.60%
Tygh Capital Management, Inc. 130,526$13,487,0002.56%
PALISADE CAPITAL MANAGEMENT, LP 428,875$44,316,0001.31%
BECK CAPITAL MANAGEMENT, LLC 22,067$2,280,0001.29%
EARNEST PARTNERS LLC 1,394,794$144,124,0001.24%
DC Investments Management, LLC 10,945$1,131,0001.24%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders